Operators with manufacturing and capital-markets track records.
Dane Stevens
Chief Executive Officer, Director & Co-Founder
CEO since October 2024; co-founder since 2020. Nearly two decades in sourcing, manufacturing, and global distribution. Focused on producing GMP-certified MDMA and natural psilocybin for regulated treatment programs.
Jacob Safarik
Chief Financial Officer & Director
Chartered Professional Accountant (CPA). 16+ years in accounting, project finance, business development, and quality assurance. Responsible for financial strategy, capital allocation, and cost management.
Bryan Safarik
Chief Operating Officer & Director
Nearly two decades of senior management across regulated industries. Former Director of Marine Operations at Ocean Fisheries Ltd. Co-founded a federally licensed cannabis production company. Oversees production and GMP-certified manufacturing.
Dr. Preston Chase
Chief Science Officer
R&D chemist with 25+ years of experience. BSc from University of Victoria; PhD from University of Calgary. 30+ peer-reviewed publications; multiple awarded and pending patents across catalysis, synthesis, and analytical chemistry.
Karina Lahnakoski
Director, Quality & Commercial Strategies
20+ years in pharmaceuticals, cannabis, and life sciences. Former Partner, Deloitte Risk Advisory. Former VP Quality & Regulatory, Cannabis Compliance Inc. BSc Biochemistry; MBA; PMP; ICD.D.
JJ Wilson
Chairman of the Board
Co-founder of Amer Sports. Capital-markets and brand-building track record spanning two decades.